{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:51:57Z","timestamp":1773409917856,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.annder.2018.07.022","type":"journal-article","created":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T08:36:49Z","timestamp":1538815009000},"page":"773-776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Non-nucleoside reverse transcriptase inhibitors (NNRTIs)-induced Stevens-Johnson syndrome and gynecomastia in an HIV-infected child: A case report"],"prefix":"10.1016","volume":"145","author":[{"given":"B.","family":"Saka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Akakpo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bassowa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.N.","family":"Dapam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mahamadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.N.","family":"Teclessou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mouhari-Toure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.Y.","family":"Laouali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mensah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kombat\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pitch\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2018.07.022_bib0070","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2431-13-120","article-title":"Efavirenz-induced gynecomastia in a prepubertal girl with human immunodeficiency virus infection: a case report","volume":"13","author":"Van Ramshorst","year":"2013","journal-title":"BMC Pediatrics"},{"key":"10.1016\/j.annder.2018.07.022_bib0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/INF.0000000000001424","article-title":"Who gets severe gynecomastia among HIV-infected children in the United Kingdom and Ireland?","volume":"36","author":"Kenny","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.annder.2018.07.022_bib0080","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1075-122X.2004.21392.x","article-title":"Efavirenz-associated gynecomastia: report of five cases and review of the literature","volume":"10","author":"Jover","year":"2004","journal-title":"Breast J"},{"key":"10.1016\/j.annder.2018.07.022_bib0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/135965350400900416","article-title":"Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment","volume":"9","author":"Mira","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1016\/j.annder.2018.07.022_bib0090","first-page":"23","article-title":"A case-control study of gynecomastia in HIV-1-infected patients receiving HAART","volume":"14","author":"Rahim","year":"2004","journal-title":"AIDS Read"},{"key":"10.1016\/j.annder.2018.07.022_bib0095","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-4632.2012.05743.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in Sub-Saharan Africa: a multicentric study in four countries","volume":"52","author":"Saka","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2018.07.022_bib0100","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/00002030-200109280-00014","article-title":"Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"15","author":"Fagot","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.annder.2018.07.022_bib0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.2004.02059.x","article-title":"Prepubertal gynaecomastia: aetiology, course and outcome","volume":"61","author":"Einav-Bachar","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.annder.2018.07.022_bib0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4314\/mmj.v28i4.8","article-title":"Gynaecomastia in two men on stable antiretroviral therapy who commenced treatment for tuberculosis","volume":"28","author":"Kratz","year":"2016","journal-title":"Malawi Med J"},{"key":"10.1016\/j.annder.2018.07.022_bib0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4314\/mmj.v27i3.11","article-title":"Breast enlargement in Malawian males on the standard first-line antiretroviral therapy regimen: case reports and review of the literature","volume":"27","author":"Kwekwesa","year":"2015","journal-title":"Malawi Med J"},{"key":"10.1016\/j.annder.2018.07.022_bib0120","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1016\/S2352-3018(16)30054-6","article-title":"Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2\/3 trial","volume":"3","author":"BREATHER (PENTA 16) Trial Group","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.annder.2018.07.022_bib0125","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1056\/NEJMoa1113249","article-title":"Nevirapine versus ritonavir boosted lopinavir for HIV infected children","volume":"366","author":"Violari","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2018.07.022_bib0130","series-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach","author":"WHO","year":"2013"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818305234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818305234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:06:19Z","timestamp":1758971179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963818305234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0151963818305234"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2018.07.022","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-nucleoside reverse transcriptase inhibitors (NNRTIs)-induced Stevens-Johnson syndrome and gynecomastia in an HIV-infected child: A case report","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2018.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}